A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.
About This Bill
Committee
Latest Action · July 21, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.